Erythropoietin Gel Effect on Dental Implant Stability

Recruiting now · Not applicable

Conditions studied: Osseointegration

In brief

* Achieving and maintaining long-term osseointegration for dental implants is a key objective in the field of dentistry. The success of osseointegration is influenced by the surface treatment applied to dental implants. Numerous coating techniques have been developed to improve and speed up osseointegration. * The aim of the current study is to assess immediate dental implant stability coated with erythropoietin gel, both clinically and radiographically. * Materials and Methods: We conducted a randomized controlled clinical trial.The sample will include patients demanding immediate implant treatment in the anterior maxilla . Patients will be randomly allocated into the two groups of the study. The group A will be treated with erythropoietin gel coated dental implant immediately after extraction of non restorable teeth in the anterior maxilla . Group B will be treated with non coated dental implant immediately after extraction of non restorable teeth in the anterior maxilla . * The primary outcome variable will be implant stability and the secondary outcome will be crestal marginal bone level and bone density around implants. It will be measured at time of implant placement and reevaluated after 6-months .

Key facts

Study ID

NCT06665451

Run by

Al-Azhar University

People needed

24

Starts

2025-03-15

Expected to finish

2026-07-01

Last updated by the study team

2026-05-18

Who can join

Age: 20 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• All patients Should have nonrestorable teeth in the anterior maxilla indicated for extraction and seeking implant placement.
• Good general periodontal health and maintenance.

You may not qualify if…

• Heavy smokers who smoke more than ten cigarettes per day
• Acute infected socket
• Ant socket with wall defect.
• Pregnency
• Local or systemic conditions that will interfere with bone healing (uncontrolled diabetes mellitus or human immune deficiency virus infections, resonance therapy), bone disorders (hyperparathyroidism, osteoporosis, or Paget's disease.
• Patients who had subjected to intravenous and/or oral bisphosphonate therapy.

Where it is running

• Faculty of dental medicine Al-Azhar university — Asyut, Asyut Governorate, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.